Health Care & Life Sciences » Pharmaceuticals | Yungjin Pharm. Co. Ltd.

Yungjin Pharm. Co. Ltd. | Ownership

Companies that own Yungjin Pharm. Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
2,082,059
1.13%
99,141
0%
07/31/2018
BlackRock Fund Advisors
1,113,793
0.61%
0
0%
09/05/2018
BlackRock Advisors (UK) Ltd.
856,242
0.47%
0
0%
09/06/2018
Norges Bank Investment Management
677,608
0.37%
181,180
0%
12/31/2017
Mirae Asset Global Investments Co., Ltd.
675,932
0.37%
-67,916
0.04%
04/30/2018
Dimensional Fund Advisors LP
371,891
0.2%
0
0%
04/30/2018
Charles Schwab Investment Management, Inc.
112,870
0.06%
0
0%
09/06/2018
SSgA Funds Management, Inc.
71,142
0.04%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
54,590
0.03%
0
0%
03/31/2018
Samsung Asset Management Co., Ltd.
46,199
0.03%
-914,092
0.02%
07/06/2018

About Yungjin Pharm. Co.

View Profile
Address
13 Olympic-ro 35da-gil
Seoul SL 05510
Korea, Republic Of
Employees -
Website http://www.yungjin.co.kr
Updated 07/08/2019
Yungjin Pharm. Co., Ltd. engages in the development, production, and distribution of pharmaceuticals. Its products include cephalosporin, antibiotics, drugs for the central nervous system, cardiovascular, endocrine system, urinary system, respiratory, anti-inflammatory and analgesics, anti-histamine, anti-fungal, total nutrition, vitamin and supplement, cosmetics, and tonic drinks.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.